{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:41:07Z","timestamp":1794375667982,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273683"],"award-info":[{"award-number":["81273683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is characterized by excessive hepatic lipid accumulation. Many studies have suggested that lipid overload is the key initial factor that contributes to hepatic steatosis. Our previous study indicated that diosgenin (DSG) has a beneficial effect on energy metabolism, but the underlying mechanism remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human normal hepatocytes (LO2 cells) were incubated with palmitic acid to establish the cell model of nonalcoholic fatty liver. The effects of DSG on lipid metabolism, glucose uptake and mitochondrial function were evaluated. Furthermore, the mechanism of DSG on oxidative stress, lipid consumption and lipid synthesis in LO2 cells was investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results indicated that palmitic acid induced obvious lipid accumulation in LO2 cells and that DSG treatment significantly reduced the intracellular lipid content. DSG treatment upregulated expression of lipolysis proteins, including phospho-AMP activated protein kinase (p-AMPK), phospho-acetyl-coA carboxylase (p-ACC) and carnitine acyl transferase 1A (CPT-1A), and inhibited expression of lipid synthesis-related proteins, including sterol regulatory element-binding protein 1c (SREBP-1c) and fatty acid synthase (FAS). Additionally, DSG-treated cells displayed a marked improvement in mitochondrial function, with less production of reactive oxygen species and a higher mitochondrial membrane potential compared with the model group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that DSG can reduce intracellular lipid accumulation in LO2 cells and that the underlying mechanism may be related to the improving oxidative stress, increasing fatty acid \u03b2-oxidation and decreasing lipid synthesis. The above changes might be mediated by the activation of the AMPK\/ACC\/CPT-1A pathway and inhibition of the SREBP-1c\/FAS pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-019-2671-9","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:39:46Z","timestamp":1568335186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK\/ACC\/CPT-1A and SREBP-1c\/FAS signaling pathways in LO2 cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Ke","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuer","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"2671_CR1","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-Tetri BA, Rinella ME. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2671_CR2","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.3390\/ijms15058591","volume":"15","author":"W Peverill","year":"2014","unstructured":"Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15(5):8591\u2013638.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2671_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376\u201388.","journal-title":"Cell Metab"},{"issue":"3","key":"2671_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2011.10.008","volume":"56","author":"J Monsenego","year":"2012","unstructured":"Monsenego J, Mansouri A, Akkaoui M, Lenoir V, Esnous C, Fauveau V, Tavernier V, Girard J, Prip-Buus C. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. J Hepatol. 2012;56(3):632\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"2671_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","volume":"19","author":"SH Koo","year":"2013","unstructured":"Koo SH. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol. 2013;19(3):210\u20135.","journal-title":"Clin Mol Hepatol"},{"issue":"26","key":"2671_CR6","doi-asserted-by":"publisher","first-page":"E5896","DOI":"10.1073\/pnas.1801745115","volume":"115","author":"J Dai","year":"2018","unstructured":"Dai J, Liang K, Zhao S, Jia W, Liu Y, Wu H, Lv J, Cao C, Chen T, Zhuang S, et al. Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis. Proc Natl Acad Sci U S A. 2018;115(26):E5896\u2013905.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2671_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/hep.24140","volume":"53","author":"JM Orellana-Gavalda","year":"2011","unstructured":"Orellana-Gavalda JM, Herrero L, Malandrino MI, Paneda A, Sol Rodriguez-Pena M, Petry H, Asins G, Van Deventer S, Hegardt FG, Serra D. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology. 2011;53(3):821\u201332.","journal-title":"Hepatology"},{"issue":"11","key":"2671_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.metabol.2013.06.012","volume":"62","author":"VL Malloy","year":"2013","unstructured":"Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Metabolism. 2013;62(11):1651\u201361.","journal-title":"Metabolism"},{"issue":"3","key":"2671_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00394-005-0576-5","volume":"45","author":"ES Shin","year":"2006","unstructured":"Shin ES, Cho SY, Lee EH, Lee SJ, Chang IS, Lee TR. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. Eur J Nutr. 2006;45(3):159\u201364.","journal-title":"Eur J Nutr"},{"issue":"1","key":"2671_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006;6(1):1\u201328.","journal-title":"Mitochondrion"},{"issue":"Suppl 5","key":"2671_CR11","doi-asserted-by":"publisher","first-page":"201S","DOI":"10.1038\/oby.2006.309","volume":"14","author":"GV Ronnett","year":"2006","unstructured":"Ronnett GV, Kleman AM, Kim EK, Landree LE, Tu Y. Fatty acid metabolism, the central nervous system, and feeding. Obesity (Silver Spring). 2006;14(Suppl 5):201S\u20137S.","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"2671_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/cbin.10915","volume":"42","author":"R Ke","year":"2018","unstructured":"Ke R, Xu Q, Li C, Luo L, Huang D. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism. Cell Biol Int. 2018;42(4):384\u201392.","journal-title":"Cell Biol Int"},{"issue":"7","key":"2671_CR13","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/humrep\/dex087","volume":"32","author":"M Schindler","year":"2017","unstructured":"Schindler M, Pendzialek M, Grybel KJ, Seeling T, Gurke J, Fischer B, Navarrete Santos A. Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts. Hum Reprod. 2017;32(7):1382\u201392.","journal-title":"Hum Reprod"},{"key":"2671_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jep.2018.12.039","volume":"233","author":"A Lingesh","year":"2019","unstructured":"Lingesh A, Paul D, Naidu V, Satheeshkumar N. AMPK activating and anti adipogenic potential of Hibiscus rosa sinensis flower in 3T3-L1 cells. J Ethnopharmacol. 2019;233:123\u201330.","journal-title":"J Ethnopharmacol"},{"key":"2671_CR15","doi-asserted-by":"publisher","first-page":"152999","DOI":"10.1016\/j.phymed.2019.152999","volume":"63","author":"JP An","year":"2019","unstructured":"An JP, Choi JH, Huh J, Lee HJ, Han S, Noh JR, Kim YH, Lee CH, Oh WK. Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS\/MS spectrometry. Phytomedicine. 2019;63:152999.","journal-title":"Phytomedicine"},{"key":"2671_CR16","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2337\/db18-0184","volume":"67","author":"Y Jiao","year":"2018","unstructured":"Jiao Y, Zhao J, Zhang Z, Li M, Yu X, Yang Y, Liu J, Liao S, Li D, Wang Y, et al. Erratum. SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c. Diabetes. 2018;67:2227\u201338 Diabetes 2019, 68(1):235.","journal-title":"Diabetes"},{"issue":"6","key":"2671_CR17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jhep.2014.06.037","volume":"61","author":"F Yan","year":"2014","unstructured":"Yan F, Wang Q, Lu M, Chen W, Song Y, Jing F, Guan Y, Wang L, Lin Y, Bo T, et al. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. J Hepatol. 2014;61(6):1358\u201364.","journal-title":"J Hepatol"},{"issue":"4","key":"2671_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2009.12.006","volume":"48","author":"YW Kim","year":"2010","unstructured":"Kim YW, Kim YM, Yang YM, Kim TH, Hwang SJ, Lee JR, Kim SC, Kim SG. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic Biol Med. 2010;48(4):567\u201378.","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"2671_CR19","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1002\/jsfa.7057","volume":"95","author":"PB Naidu","year":"2015","unstructured":"Naidu PB, Ponmurugan P, Begum MS, Mohan K, Meriga B, RavindarNaik R, Saravanan G. Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats. J Sci Food Agric. 2015;95(15):3177\u201382.","journal-title":"J Sci Food Agric"},{"issue":"Suppl 1","key":"2671_CR20","first-page":"422","volume":"16","author":"WL Xue","year":"2007","unstructured":"Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007;16(Suppl 1):422\u20136.","journal-title":"Asia Pac J Clin Nutr"},{"key":"2671_CR21","doi-asserted-by":"publisher","first-page":"7493694","DOI":"10.1155\/2016\/7493694","volume":"2016","author":"K Fang","year":"2016","unstructured":"Fang K, Dong H, Jiang S, Li F, Wang D, Yang D, Gong J, Huang W, Lu F. Diosgenin and 5-Methoxypsoralen ameliorate insulin resistance through ER-alpha\/PI3K\/Akt-signaling pathways in HepG2 cells. Evid Based Complement Alternat Med. 2016;2016:7493694.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"2671_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3945\/an.114.007807","volume":"6","author":"S Fuller","year":"2015","unstructured":"Fuller S, Stephens JM. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Adv Nutr. 2015;6(2):189\u201397.","journal-title":"Adv Nutr"},{"issue":"5","key":"2671_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, Herder C, Carstensen M, Krausch M, Knoefel WT, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015;21(5):739\u201346.","journal-title":"Cell Metab"},{"issue":"3","key":"2671_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI34275","volume":"118","author":"C Postic","year":"2008","unstructured":"Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest. 2008;118(3):829\u201338.","journal-title":"J Clin Invest"},{"issue":"5","key":"2671_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343\u201351.","journal-title":"J Clin Invest"},{"issue":"4","key":"2671_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.26226","volume":"58","author":"K Begriche","year":"2013","unstructured":"Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology. 2013;58(4):1497\u2013507.","journal-title":"Hepatology"},{"issue":"5","key":"2671_CR27","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.3390\/ijms15058713","volume":"15","author":"F Nassir","year":"2014","unstructured":"Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(5):8713\u201342.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2671_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF. Steatohepatitis: a tale of two \"hits\"? Gastroenterology. 1998;114(4):842\u20135.","journal-title":"Gastroenterology"},{"issue":"39","key":"2671_CR29","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","volume":"20","author":"G Paradies","year":"2014","unstructured":"Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(39):14205\u201318.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2671_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"AP Rolo","year":"2012","unstructured":"Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012;52(1):59\u201369.","journal-title":"Free Radic Biol Med"},{"key":"2671_CR31","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","volume":"2018","author":"M Masarone","year":"2018","unstructured":"Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxidative Med Cell Longev. 2018;2018:9547613.","journal-title":"Oxidative Med Cell Longev"},{"key":"2671_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40360-016-0059-8","volume":"17","author":"ZR Yang","year":"2016","unstructured":"Yang ZR, Wang HF, Zuo TC, Guan LL, Dai N. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats. BMC Pharmacol Toxicol. 2016;17:16.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"8","key":"2671_CR33","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/nu11081779","volume":"11","author":"Nakamura","year":"2019","unstructured":"Nakamura A, Kitamura N, Yokoyama Y, Uchida S, Kumadaki K, Tsubota K, Watanabe M. Melon GliSODin((R)) Prevents Diet-Induced NASH Onset by Reducing Fat Synthesis and Improving Liver Function. Nutrients. 2019;11(8):E1779.","journal-title":"Nutrients"},{"issue":"1\u20133","key":"2671_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejphar.2012.06.038","volume":"691","author":"L Pari","year":"2012","unstructured":"Pari L, Monisha P, Mohamed Jalaludeen A. Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats. Eur J Pharmacol. 2012;691(1\u20133):143\u201350.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2671_CR35","first-page":"578","volume":"13","author":"Y Chen","year":"2015","unstructured":"Chen Y, Tang YM, Yu SL, Han YW, Kou JP, Liu BL, Yu BY. Advances in the pharmacological activities and mechanisms of diosgenin. Chin J Nat Med. 2015;13(8):578\u201387.","journal-title":"Chin J Nat Med"},{"issue":"1","key":"2671_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12031-017-0953-6","volume":"63","author":"J Wang","year":"2017","unstructured":"Wang J, Xiao B, Han F, Shi Y. Metformin alleviated the neuronal oxidative stress in Hippocampus of rats under single prolonged stress. J Mol Neurosci. 2017;63(1):28\u201335.","journal-title":"J Mol Neurosci"},{"issue":"23","key":"2671_CR37","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1016\/j.febslet.2006.08.040","volume":"580","author":"NE Wolins","year":"2006","unstructured":"Wolins NE, Brasaemle DL, Bickel PE. A proposed model of fat packaging by exchangeable lipid droplet proteins. FEBS Lett. 2006;580(23):5484\u201391.","journal-title":"FEBS Lett"},{"issue":"4","key":"2671_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2671_CR39","doi-asserted-by":"crossref","unstructured":"Foretz M, Even PC, Viollet B. AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo. Int J Mol Sci. 2018:19(9):E2826.","DOI":"10.3390\/ijms19092826"},{"key":"2671_CR40","doi-asserted-by":"crossref","unstructured":"Lally JSV, Ghoshal S, DePeralta DK, Moaven O, Wei L, Masia R, Erstad DJ, Fujiwara N, Leong V, Houde VP, et al. Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma. 2018;29(1):174\u201382 e175.","DOI":"10.1016\/j.cmet.2018.08.020"},{"issue":"12","key":"2671_CR41","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1194\/jlr.R025882","volume":"53","author":"RA Srivastava","year":"2012","unstructured":"Srivastava RA, Pinkosky SL, Filippov S, Hanselman JC, Cramer CT, Newton RS. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J Lipid Res. 2012;53(12):2490\u2013514.","journal-title":"J Lipid Res"},{"issue":"2","key":"2671_CR42","first-page":"1089","volume":"41","author":"S Cheng","year":"2018","unstructured":"Cheng S, Liang S, Liu Q, Deng Z, Zhang Y, Du J, Zhang Y, Li S, Cheng B, Ling C. Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways. Int J Mol Med. 2018;41(2):1089\u201395.","journal-title":"Int J Mol Med"},{"issue":"12","key":"2671_CR43","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.bbalip.2015.08.007","volume":"1851","author":"X Deng","year":"2015","unstructured":"Deng X, Dong Q, Bridges D, Raghow R, Park EA, Elam MB. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase. Biochim Biophys Acta. 2015;1851(12):1521\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2671_CR44","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1074\/jbc.M111421200","volume":"277","author":"G Liang","year":"2002","unstructured":"Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting\/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem. 2002;277(11):9520\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"2671_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cub.2014.12.034","volume":"25","author":"E Davie","year":"2015","unstructured":"Davie E, Forte GM, Petersen J. Nitrogen regulates AMPK to control TORC1 signaling. Curr Biol. 2015;25(4):445\u201354.","journal-title":"Curr Biol"},{"issue":"3","key":"2671_CR46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung YL, Schulze A. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008;8(3):224\u201336.","journal-title":"Cell Metab"},{"issue":"4","key":"2671_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.bbrc.2016.11.101","volume":"482","author":"Y Yin","year":"2017","unstructured":"Yin Y, Gao L, Lin H, Wu Y, Han X, Zhu Y, Li J. Luteolin improves non-alcoholic fatty liver disease in db\/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c. Biochem Biophys Res Commun. 2017;482(4):720\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2671_CR48","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1248\/bpb.b17-00724","volume":"41","author":"Q Wang","year":"2018","unstructured":"Wang Q, Liu S, Zhai A, Zhang B, Tian G. AMPK-mediated regulation of lipid metabolism by phosphorylation. Biol Pharm Bull. 2018;41(7):985\u201393.","journal-title":"Biol Pharm Bull"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2671-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:08:28Z","timestamp":1599851308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2671-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2671"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2671-9","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All of the procedures were reviewed and approved by the Animal Ethics Committee of Tongji Medical College, Huazhong University of Science & Technology before and during the experiment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}